OPGN Would you buy something that was 1000x more expensive?

6/9/2020 Alliance Global Partners Reiterated Rating to Buy and target price to $5.00

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease.

Aug 11 Reuters:
OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers

Aug 9 Reuters:
OpGen Co-Markets COVID-19 Antibody Test Kit.
OpGen is marketing and promoting the CELLSEARCH system, CELLSEARCH CEC kit, and certain COVID-19 related products that are sold and distributed by MSB on a non-exclusive basis

Market cap. 34.511M
Net income: -12.446M
Annual Sales $3.50 million


If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.